An in-depth look to APROGEN BIOLOGICS operating, investing, and financing activities

003060 free cash flow for Q3 24 is -12.26 B KRW. For 2023, 003060 free cash flow was -61.74 B KRW and operating cash flow was -33.65 B KRW.